Experion Holdings Ltd.

publicPublic Group

Experion Holdings Ltd. is the parent company of Experion Biotechologies Inc., a Health Canada licensed cultivation and processor of Cannabis, based in Mission, BC; and EFX Labs, a medical products production and clinical research company based in Calgary, AB.

people16 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
  • Thumb 20190424 083700 film4 1
Join Group


Experion Holdings Ltd.

publicPublicGroup

Experion Holdings Ltd. is the parent company of Experion Biotechologies Inc., a Health Canada licensed cultivation an......

people16 Members       (0)

Judy-Ann Pottinger posted an update WHAT HAPPENS WHEN THE ‘’HIGH’’ WEARS OFF? in EXPERION HOLDINGS LTD.

Dear Investors and Members


The cannabis sector has seen a lot of shake-ups in the last quarter and that in and of itself is an understatement. 


The sector seems to swing back and forth, week to week, even day to day. Sometimes based on big news, but sometimes not. Sometimes the news is on a single company.  In the last weeks we have seen Canopy bid farewell to its Founder, Aphria saw its two co-founders and former chief executive exit stage left and CannTrust’s former co-founder and CEO step down, but let’s not get lost in the weeds


Why all this change – this shuffle?  Greg Taylor, chief investment officer of Purpose Investments, which runs the Purpose Marijuana Opportunities Fund said this “Look, the industry needs to mature. These people founded companies on the concept of cannabis legalization, and now it has happened, so there needs to be a focus on operations. Your products have to be up and running and good,”


“All these companies are now going to have to look at their management and see if they are actually up for this task of delivering the goods.”


https://business.financialpost.com/cannabis/cannabis-business/lintons-firing-signals-it-is-time-for-cannabis-industry-to-start-delivering


Over the past 7 to 10 days I have spoken to a plethora of Experion shareholders and investors looking at Experion who have asked about Experion and specifically wanting to know more about Jay Garnett our CEO.  One of those conversations really resonated with me and frankly I thought ‘’Eureka’’ – THIS is it!!! Let me share it with you  ‘’Hey Judy-Ann what’s the one business acumen that stands out most when it comes to Jay Garnett, from what I can gather thus far, he is a master of splitting a dollar into four and keeping burn rates down….”


Bigger does not translate into better… Jay Garnett stepped into the CEO of Experion (formerly Viridium Pacific) in October 2018 with a mandate to steer the company through its next phase of growth.  A huge task but one Garnett is more than capable of doing.  His Curriculum Vitae boasts a long history of ‘’building companies’’, ‘’re-building companies’’ and he knows how to build a Team.


“Throughout my entrepreneurial career, I have focused on being ahead of consumer trends, behavioral shifts and finding ways to bridge product offerings with consumer desires.  Now at Experion I have a unique opportunity to define and educate the market through one of the largest shifts in consumer goods in history” Jay Garnett – October 15, 2018


https://www.experionwellness.com/viridium-pacific-group-names-new-ceo-2/


“We’re in the cannabis space, and I think for a lot of people that that’s very confusing. I think there are so many licenses out there and people don’t really understand how the Health Canada’s licensing system works so, if I was going to break it down, I would say that we are a licensed cultivator and seller of cannabis within the industry, and our goal is to ensure that our quality cannabis is vertically integrated from there into our own products, primarily focused in the medical space.”  Jay Garnett


Not overly complicated. Grow it well, then put it out through a series of pipelines to whomever wants to buy it for a premium.  That doesn’t require tens of millions of dollars raised every few months for ongoing hype sales letters on Instagram. Just do the work. Right? Jay Garnett – June 3, 2019 Equity Guru interview with Chris Parry


https://equity.guru/2019/06/03/experion-biotechnologies-vir-v-starts-telling-story-get-savings/


Follow us in Experion’s Global Investor Forum for continued updates and insights  http://connects.company/ExperionEXP


 

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Holdings Ltd. Trading on Frankfurt Stock Exchange Under New Company Name in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / July 3, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31), formerly Viridium Pacific Group Ltd., announced today that its shares are now trading on the Frankfurt Stock Exchange under the Company's new name Experion Holdings Ltd. The symbol and WKN have not changed and remains ''MB31" and ''WKN:A2PLZG".


The Company's shares continue to be listed on the TSXV under the ticker ''EXP" and on the OTCQB market in the US under the ticker "EXPFF"


Mr. Jay Garnett, Chief Executive Officer commented, "Experion is pursuing international growth strategies, such as the vast export market in countries with early opportunities. Having our new name reflected on the Frankfurt Stock Exchange will allow us to grow our shareholder base throughout Europe and attract global recognition as we work diligently to unlock value for our current shareholders and new shareholders to come"


The Frankfurt Stock Exchange is one of the world's largest trading centres for securities. With a share in turnover of around 90 per cent, it is the largest of Germany's seven stock exchanges and it is an international trading centre, which is reflected in the structure of its participants. Of the approximately 200 market participants, roughly 50% are from countries other than Germany.


On June 25th Experion announced an LOI with a Polish Import and Distribution Company. The LOI will see Experion exporting medical flower products to Poland for scientific purposes enabling the Polish Company to test and develop Experion's flower products. Ultimately Experion's goal is to export increased quantities of its flower products into Poland for medical use.


Mr. Jay Garnett further commented "As investor interest and momentum in the cannabis industry continues to accelerate, Experion will be well-positioned to participate in the European and global cannabis markets as they continue to expand, and we receive our EU GMP certification that will allow Experion products to be exported across Europe."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/550713/Experion-Holdings-Ltd-Trading-on-Frankfurt-Stock-Exchange-Under-New-Company-Name

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Announces Letter of Intent with Polish Import and Distribution Company in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 25, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31), formerly Viridium Pacific Group Ltd., is pleased to announce that it has signed a non-binding Letter of Intent (''LOI'') with a Polish Import and distribution Company (''Polish Company'') to export medical flower products to Poland for scientific purposes.


The executed LOI consist of two parts, part one, will see Experion exporting medical flower products to Poland for scientific purposes enabling the Polish Company to test and develop Experion's flower products. Upon the successful testing and development of the flower products and once a viable export and import channel has been established between Canada and Poland, part two of the LOI will commence which will see Experion exporting increased quantities of its flower products into Poland for medical use. Experion will also have completed its EU GMP certification which will allow for part two of the LOI.


Mr. Jay Garnett, Chief Executive Officer commented, "The LOI represents a major milestone for Experion. As medical marijuana becomes more legalized around the world, Experion continues to focus on the vast export market in countries with early opportunities. By exporting products for scientific research, we are able to move past barriers to entry and be one of the first Canadian producers to enter Poland"


Pursuant to the LOI, Experion and the Polish Import Company will work towards a definitive agreement as Experion seeks to increase export opportunities in Europe and continue to build Experion's international distribution chain.


Mr. Jay Garnett further commented "I am truly proud of the work that the team has done and the great strides we have made to date. This is yet another result of solid teamwork that can only be achieved by having a shared vision and goal as we work diligently to unlock value for our most important asset and audience - our shareholders.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/549774/Experion-Announces-Letter-of-Intent-with-Polish-Import-and-Distribution-Company

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion's Brand, Kanabé Goods Co., Well Positioned to Take Advantage of New Health Canada Regulations in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 21, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF), formerly Viridium Pacific Group Ltd., is pleased to provide an update on the Company's brands positioned to take advantage of Health Canada's final regulations for Value-Add Products (VAP's) such as cannabis topicals, edibles and extracts as well as Health Canada's proposal to create a new category ''Cannabis Health Products'' for therapeutic treatment of minor ailments like sleeplessness or sore muscles or for use in pets, paving the way for large new untapped market.


Mr. Jay Garnett, Chief Executive Officer commented "Experion is in continued development of our wellness-centric brand Kanabé Goods Co. www.kanabe.ca for the launch of value-add products (VAP's). There are currently 50 plus existing formulations which we have the ability to produce in our facility and we are also working with key strategic partners for large scale commercial roll-out. These health and wellness products such as non-intoxicating topicals and micro-dosed oils are an entry point for new consumers, broadening the market potential. The Experion management team has decades of experience in consumer-packaged goods and is well positioned to be a first mover in this category which in turn will enable Experion to stand firm in our commitment of unlocking value for our shareholders"


The VAP's regulations come into force October 17, 2019 with product availability earliest December 16th, 2019. Furthermore, Health Canada's proposal for Cannabis Health Products opens the door for a bigger opportunity. The proposal looks to treat health and wellness products with cannabis, similar to Natural Health Products which allows the product to make health claims based on evidence but without the oversight of a practitioner.


Mr. Garnett further commented "A Kanabé topical balm that is non-intoxicating, for example, could potentially be sold via pharmacies or online without the restrictions to have a medical cannabis prescription or buy through a licensed cannabis retailer. The accessibility to purchase is much easier on the consumer, as well as the use of the product much clearer." This proposal further aligns to our educational and public outreach efforts from our Cannabis Wellness Expert and Co-Founder of Kanabé, Krystal Laferriere, who had created the product line to soothe side-effects and other ailments suffered as a result of her Crohn's Disease."


Health Canada is asking the public to submit feedback on this new category via consultation paper until September 3rd.


https://www.canada.ca/en/health-canada/programs/consultation-potential-market-cannabis.html


Health Canada Final Regulations for Value-Add Products


https://www.canada.ca/en/health-canada/news/2019/06/health-canada-finalizes-regulations-for-the-production-and-sale-of-edible-cannabis-cannabis-extracts-and-cannabis-topicals.html


About Kanabe Goods Co


Kanabé Goods Co. www.kanabe.ca creates therapeutic health and wellness products containing cannabis and has over 50 formulations in its portfolio including topical salves, lotions, oils as well as edible oils and capsules. Kanabé products were developed to target and soothe various aliments by combining cannabinoids, terpenes and aromatherapy with a focus on discretion and ease of use by developing products that are already found in consumers everyday life. Kanabé is an adult-use, over-the-counter health & wellness brand ingraining into daily actions and rituals for comfort and solutions to acute problems ranging from sore muscles, to sleep and skin issues.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Experion Holdings Ltd
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd


View source version on accesswire.com:
https://www.accesswire.com/549436/Experions-Brand-Kanab-Goods-Co-Well-Positioned-to-Take-Advantage-of-New-Health-Canada-Regulations

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Holdings Ltd Announces Its U.S. Listing on OTCQB Under the Symbol EXPFF in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 19, 2019 / Experion Holdings Ltd. ("Experion" or the  "Company") (TSX-V: EXP) (OTCQB: EXPFF), formerly Viridium Pacific Group Ltd., today announced it has qualified to trade on the OTCQB Venture Market. Experion also has the intention to seek The Depositary Trust Company ("DTC") eligibility.


The common shares of Experion will begin trading on the OTCQB, effective immediately, under the ticker symbol "EXPFF." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.


Mr. Jay Garnett, Chief Executive Officer, commented "We are proud to qualify for a listing on the OTCQB marketplace.  This is an important step and milestone for the Company as it aims to increase its presence among American retail and institutional investors. This move will provide investors with additional liquidity and increased trading capacity and reaffirms to the markets that we are indeed committed to unlocking value for our shareholders".


Experion will continue to trade on the TSX Venture Exchange under its existing symbol "EXP".


About OTCQB Venture


The OTCQB Venture is the premier marketplace for entrepreneurial and development stage U.S. and international companies that are committed to providing a high-quality trading and information experience for their US investors. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB Venture quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB. 


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd 


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com 


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/549207/Experion-Holdings-Ltd-Announces-Its-US-Listing-on-OTCQB-Under-the-Symbol-EXPFF

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Announces Resignation of Board Member in EXPERION HOLDINGS LTD.

VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / June 17, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP), formerly Viridium Pacific Group Ltd., wishes to announce that Michael Kohut has resigned from the board of directors of Experion effectively immediately.


Mr. Jay Garnett, Chief Executive Officer, commented, "We would like to thank Mike for his efforts and contributions. We are in the process of evaluating candidates that will strengthen our board and support management in unlocking value for all shareholders."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548952/Experion-Announces-Resignation-of-Board-Member

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Adds Veteran Financial and Business Magnate to Board of Directors with the Appointment of William (Bill) Kenneth Dickie in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 11, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSX-V: EXP), formerly Viridium Pacific Group Ltd., is pleased to announce the appointment of a new member to its Board of Directors. Mr. William (Bill) Kenneth Dickie will join Mr. Jay Garnett, Chief Executive Officer of Experion Holdings Ltd, on the Board of Directors effective June 11, 2019.


Mr. Dickie brings substantial financial oversight and business advisory experience to Experion's Board. Mr. Dickie is currently, the Co‐Chief Investment Officer and a Portfolio Manager at Matco Financial, a Calgary, Alberta based independent discretionary investment counsellor and asset management firm. Mr. Dickie has over thirty-five (35) years of experience in the financial and investment industry, and is responsible for the investment operations and strategic development of Matco Financial Inc. He is a member of the Investment Committee, Asset Mix Committee and Chair of the Equity Working Group. As the Co-Chief Investment Officer of Matco Financial Inc., he has oversight of the Matco Investment Platform.


Mr. Dickie has been helping private clients achieve their goals since 1979, starting his career with McLeod Young Weir Ltd. Prior to co-founding Matco Financial Inc. in 2006, Mr. Dickie was President and Director of Fiduciary Trust Company of Canada, formerly part of Bissett Investment Management. where he established a new business strategy and model. Mr. Dickie graduated from the University of Alberta having earned a Bachelor of Commerce and holds the Chartered Financial Analyst designation.


"Bill brings a wealth of financial and governance expertise" said Jay Garnett, CEO of Experion Holding Ltd. "his appointment furthers our commitment to a strong and relevant board. Bill's addition to the Board is significant as he brings deep knowledge of the cannabis industry through his role as Co-Chief Investment Officer and one of the Lead Portfolio Managers of the Matco's Cannabis Fund; as well as extensive financial and deal-making skills. His firsthand approach to mentoring and building new companies in fast growing industries will be invaluable to Experion. We look forward to Bill's guidance as we continue to execute on our strategic objectives for 2019 to unlock value and grow Experion's market valuation."


Mr. Dickie was an early investor in EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, Alberta, which Experion acquired in February 2019.


Mr. Dickie commented, "I am pleased to be joining the Board of Experion at this important inflection point in the Company's history within an exciting and dynamic market environment. As Experion embarks on a period of tremendous growth and differentiation, I look forward to working with Jay and the management team".


Resignation of Sean McNeil


Mr. Sean MacNeil has recently resigned from his position as a Director on Experion's Board of Directors to focus on other matters. Mr. Jay Garnett added, "We wish to sincerely thank Sean for his important contributions as a key contributor in the Company's evolution and growth over the last several years. We wish him well in his future endeavors."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd


View source version on accesswire.com:
https://www.accesswire.com/548360/Experion-Adds-Veteran-Financial-and-Business-Magnate-to-Board-of-Directors-with-the-Appointment-of-William-Bill-Kenneth-Dickie

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium Pacific Group Ltd. Announces Name Change to Experion Holdings Ltd. in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 10, 2019 / Viridium Pacific Group Ltd. (the ''Company") (TSX-V: VIR ) is pleased to announce that the Company has changed its name from "Viridium Pacific Group Ltd." to "Experion Holdings Ltd." (TSX-V: EXP).The Company's shareholders approved the name change at a special meeting of shareholders held on May 31, 2019. Effective on market opening on June 10, 2019, the common shares of the Company will commence trading on the TSX Venture Exchange under the Company's new name, Experion Holdings Ltd., and under the trading symbol ''EXP". With the new change in name, there is no consolidation of capital and the CUSIP Number will be 30219B109.


Mr. Jay Garnett, Chief Executive Officer, commented, "We are excited to have both our Licence and corporate entity under Experion. Having a focused brand strategy, under one corporate brand, will bring alignment to the market and our shareholders. In addition, it will allow us to better communicate our value proposition as we work to unlock value and communicate our accomplishments to the market and stakeholders."


No action is required to be taken by current shareholders in connection with the change in name and no change has been made to Experion Holdings Ltd. share capital.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


A new Company website will be rolled out in the following weeks, for now please visit www.viridiumpacific.com or contact our Investor Relations Consultant (details below) for further information.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548214/Viridium-Pacific-Group-Ltd-Announces-Name-Change-to-Experion-Holdings-Ltd

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Biotechnologies Inc's Krystal Laferriere Sits on Panel at Lift & Co Expo Consumer Weekend in EXPERION HOLDINGS LTD.

VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / June 8, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) the parent company of Experion Biotechnologies Inc. ("Experion"), a Health Canada licensed cultivator and processor of Cannabis is pleased to announce that the Company will take part in a panel discussion at the Lift & Co. Expo Consumer Weekend on June 9th in Toronto.


Krystal Laferriere, Marketing Manager Experion Wellness, will sit on a panel with industry heavyweights such as Dr. Ira Price, Assistant Clinical Professor Emergency Medicine at McMaster University, and NextLeaf Solutions CEO, Paul Pedersen. The panel discussion will take place at the Expo Consumer Weekend on Sunday June 9th at 2:20pm to 3:00pm EST on Cannabis, Clarity & Wellness - New and Overdue Treatments and Therapies.


CEO Jay Garnett commented "We are excited to have Krystal be a key contributor and presenter at the upcoming Lift & Co Expo. Krystal is Experion's ambassador, a trusted and resonant voice in the medical Cannabis space. Krystal has fostered a large following on social media primarily because of her personal struggles with Crohn's disease and her ultimate discovery of cannabis as a therapy. Having Krystal as Experion's Cannabis Wellness Expert spearheading cannabis education, marketing and brand ambassadorship, enables Experion to have an authentic voice as we position Experion to be a dominant producer of a wide spectrum of cannabis products in the near future."


We invite all attendess of the Lift & Co Expo to join us on Sunday, June 9th at 2:20 pm to 3:00 pm.


CEO Jay Garnett further commented "We are excited about the many ways our products can enhance wellness, helping people sleep better and alleviating a range of chronic conditions. We are proud of our progress in the pain management field, particularly with our two-piece pill. It is the only cannabis product in Canada to have reached stage three clinical trials for post-operative pain relief."


Lift & Co. (TSXV: LIFT) is a cannabis-focused technology and media company that monetizes a platform of advertising solutions, events, and data insights to enable cannabis businesses to better understand, target and ultimately monetize cannabis consumers. Lift & Co. operates a leading product-comparison resource of federally regulated cannabis products; provides customized marketing solutions and data-backed insights into consumer and product trends; and connects businesses and consumers through its digital platform, and at its leading events, the Retail Tradeshows, the Lift & Co. Expos and the Canadian Cannabis Awards. The Lift & Co. Cannabis Retail Training Certification, developed in an exclusive partnership with MADD Canada, is available to both government and private clients. Learn more at lift.co.


Viridium Pacific Group Ltd. and its wholly owned subsidiary, Experion Biotechnologies Inc., together with one of its directors and several other named defendants were named in a civil claim filed by an ex-CEO of Viridium, Stephen Serenas. Mr. Serenas is seeking damages among other remedies, for breach of contract and wrongful dismissal for his employment as CEO of Viridium in the form of 10,270,437 shares of Viridium, or, alternatively, $5,546,035 as cash in lieu of the shares; in addition to 149,625 restricted stock units fully vested in Viridium. Management considers this claim to be without merit and both Viridium and Experion intend to vigorously defend the action.


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact:


Viridium Pacific Group Ltd.


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8.


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548151/Experion-Biotechnologies-Incs-Krystal-Laferriere-Sits-on-Panel-at-Lift-Co-Expo-Consumer-Weekend

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium Pacific Group Announces Results Of Annual General Meeting in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 6, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) is pleased to announce the results of its annual general and special meeting of shareholders held on May 31, 2019 (the "Meeting").


The Company put forward the following resolutions to be voted on by shareholders at the Meeting, all of which were approved:


(i) Appointment of MNP LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.


(ii) Fixing the number of directors of the Company at seven (7);


(iii) The election of directors - 01. Michael Black 02. Joel Dumaresq 03. Deni Echino 04. Jay Garnett 05. Michael Kohut 06. Sean MacNeil 07. Harry McWatters


(iv) Approve a special resolution to change the name of the Corporation to Experion Holdings Ltd.


(v) Approval of the Corporation's stock option plan


Each of the directors elected at the meeting being, Michael Black, Joel Dumaresq, Deni Echino, Jay Garnett, Michael Kohut, Sean MacNeil and Harry McWatters will hold office until the next annual meeting of the Company or until their earlier resignation or removal. Mr. Harry McWatters accepted the role of Chairman for the ensuing year, Mr. Joel Dumaresq was appointed the Audit Chair and Mr. Michael Black was appointed the Compensation and Nominations Chair.


In addition, the Company granted 156,250 Restricted Stock Units ("RSUs") to its directors and a former director, of which 25,000 RSUs will vest on May 31, 2020 and the remaining 131,250 RSUs will vest 12 months after the directors resign.


CEO Jay Garnett commented. "We are pleased to have our board elected with high acceptance of our voting shareholders. Having a strong Board is fundamental to Experion as we move forward with our strategy to unlock value and grow Experion's valuation in the marketplace. Our focused mandate to unlock value in our licenses, in our team and in our strategy gives Experion a sound footing in building a progressive cannabis company regionally, nationally and internationally."


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/547926/Viridium-Pacific-Group-Announces-Results-Of-Annual-General-Meeting

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Biotechnologies Inc's Krystal Laferriere Sits on Panel at Lift & Co Expo Consumer Weekend in EXPERION HOLDINGS LTD.

VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / June 8, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) the parent company of Experion Biotechnologies Inc. ("Experion"), a Health Canada licensed cultivator and processor of Cannabis is pleased to announce that the Company will take part in a panel discussion at the Lift & Co. Expo Consumer Weekend on June 9th in Toronto.


Krystal Laferriere, Marketing Manager Experion Wellness, will sit on a panel with industry heavyweights such as Dr. Ira Price, Assistant Clinical Professor Emergency Medicine at McMaster University, and NextLeaf Solutions CEO, Paul Pedersen. The panel discussion will take place at the Expo Consumer Weekend on Sunday June 9th at 2:20pm to 3:00pm EST on Cannabis, Clarity & Wellness - New and Overdue Treatments and Therapies.


CEO Jay Garnett commented "We are excited to have Krystal be a key contributor and presenter at the upcoming Lift & Co Expo. Krystal is Experion's ambassador, a trusted and resonant voice in the medical Cannabis space. Krystal has fostered a large following on social media primarily because of her personal struggles with Crohn's disease and her ultimate discovery of cannabis as a therapy. Having Krystal as Experion's Cannabis Wellness Expert spearheading cannabis education, marketing and brand ambassadorship, enables Experion to have an authentic voice as we position Experion to be a dominant producer of a wide spectrum of cannabis products in the near future."


We invite all attendess of the Lift & Co Expo to join us on Sunday, June 9th at 2:20 pm to 3:00 pm.


CEO Jay Garnett further commented "We are excited about the many ways our products can enhance wellness, helping people sleep better and alleviating a range of chronic conditions. We are proud of our progress in the pain management field, particularly with our two-piece pill. It is the only cannabis product in Canada to have reached stage three clinical trials for post-operative pain relief."


Lift & Co. (TSXV: LIFT) is a cannabis-focused technology and media company that monetizes a platform of advertising solutions, events, and data insights to enable cannabis businesses to better understand, target and ultimately monetize cannabis consumers. Lift & Co. operates a leading product-comparison resource of federally regulated cannabis products; provides customized marketing solutions and data-backed insights into consumer and product trends; and connects businesses and consumers through its digital platform, and at its leading events, the Retail Tradeshows, the Lift & Co. Expos and the Canadian Cannabis Awards. The Lift & Co. Cannabis Retail Training Certification, developed in an exclusive partnership with MADD Canada, is available to both government and private clients. Learn more at lift.co.


Viridium Pacific Group Ltd. and its wholly owned subsidiary, Experion Biotechnologies Inc., together with one of its directors and several other named defendants were named in a civil claim filed by an ex-CEO of Viridium, Stephen Serenas. Mr. Serenas is seeking damages among other remedies, for breach of contract and wrongful dismissal for his employment as CEO of Viridium in the form of 10,270,437 shares of Viridium, or, alternatively, $5,546,035 as cash in lieu of the shares; in addition to 149,625 restricted stock units fully vested in Viridium. Management considers this claim to be without merit and both Viridium and Experion intend to vigorously defend the action.


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact:


Viridium Pacific Group Ltd.


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8.


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548151/Experion-Biotechnologies-Incs-Krystal-Laferriere-Sits-on-Panel-at-Lift-Co-Expo-Consumer-Weekend

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium Pacific Group Announces Results Of Annual General Meeting in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 6, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) is pleased to announce the results of its annual general and special meeting of shareholders held on May 31, 2019 (the "Meeting").


The Company put forward the following resolutions to be voted on by shareholders at the Meeting, all of which were approved:


(i) Appointment of MNP LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.


(ii) Fixing the number of directors of the Company at seven (7);


(iii) The election of directors - 01. Michael Black 02. Joel Dumaresq 03. Deni Echino 04. Jay Garnett 05. Michael Kohut 06. Sean MacNeil 07. Harry McWatters


(iv) Approve a special resolution to change the name of the Corporation to Experion Holdings Ltd.


(v) Approval of the Corporation's stock option plan


Each of the directors elected at the meeting being, Michael Black, Joel Dumaresq, Deni Echino, Jay Garnett, Michael Kohut, Sean MacNeil and Harry McWatters will hold office until the next annual meeting of the Company or until their earlier resignation or removal. Mr. Harry McWatters accepted the role of Chairman for the ensuing year, Mr. Joel Dumaresq was appointed the Audit Chair and Mr. Michael Black was appointed the Compensation and Nominations Chair.


In addition, the Company granted 156,250 Restricted Stock Units ("RSUs") to its directors and a former director, of which 25,000 RSUs will vest on May 31, 2020 and the remaining 131,250 RSUs will vest 12 months after the directors resign.


CEO Jay Garnett commented. "We are pleased to have our board elected with high acceptance of our voting shareholders. Having a strong Board is fundamental to Experion as we move forward with our strategy to unlock value and grow Experion's valuation in the marketplace. Our focused mandate to unlock value in our licenses, in our team and in our strategy gives Experion a sound footing in building a progressive cannabis company regionally, nationally and internationally."


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium Pacific Group Ltd. Becomes a Member of the 8020 Community and Announces Annual General Meeting to be Held May 31, 2019 in EXPERION HOLDINGS LTD.

VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / May 13, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) is pleased to announce that Viridium is now a member of the 8020 Connect Inc. ("8020 Connect") investor community.


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect.


Join here: http://connects.digital/Viridium8


The 8020 platform enables Viridium to keep the investment community abreast of current developments such as corporate updates and engage directly with investors through a social media portal. 8020 Connect was the first social media platform to connect existing and potential investors to the Executive Management teams of publicly traded companies. The interactive structure of the portal provides an opportunity for interested parties to communicate with Viridium and supports the development of the Company's investor audience.
Mr. Jay Garnett, Chief Executive Officer, commented: "Viridium is committed to increasing our engagement with our investment community. With the recent appointment of our Investor Relations Ambassador and now 8020 Connect's social media platform, we look forward to further direct communication with our stakeholders and investors."


Mr. D'Arcy Funfer, President of 8020 Connect, stated: "In addition to expanding our platform, 8020 Connect has been successfully expanding our investor network. This network will help Viridium, and other companies on our platform, launch their social media presence and increase their investor audience through active participation."


Annual General Meeting of Shareholders Announcement


Viridium Pacific Group Ltd. announces that its Annual General and Special Meeting of Shareholders (AGM) will be held at Suite 1600, 650 West Georgia Street, Vancouver, British Columbia on Friday May 31, 2019 at 11:00 a.m. (Pacific Time).


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.
Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


About 8020 Connect


8020 Connect Inc. is a social and interactive investment community portal which expands the way shareholders and interested investors access and gather information from public corporations. Built as a hybrid social media and shareholder and management engagement platform, corporations can direct the flow of information to prospective and existing investors through both static and dynamic content. This will allow public companies to build their investment brand and investor awareness while maintaining digital media and regulatory compliance in a growing online investment community.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.
Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.




View source version on accesswire.com:
https://www.accesswire.com/545114/Viridium-Pacific-Group-Ltd-Becomes-a-Member-of-the-8020-Community-and-Announces-Annual-General-Meeting-to-be-Held-May-31-2019

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Partners with Micro-Cultivators in the Emerging Craft Growing Industry in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / May 8, 2019 / Viridium Pacific Group Ltd. ('Viridium' or the 'Company') (TSX-V: VIR) (OTC PINK: VIRFF) is pleased to announce its wholly owned subsidiary, Experion Biotechnologies Inc. ('Experion'), a licensed cultivator and processing company under the Cannabis Act, recently supplied 600 clones to one of the first licensed Micro-Cultivators in Canada through a buy back option agreement.


Located in British Columbia ('BC'), the Micro-Cultivator received 600 clones with an option for Experion to purchase the flower back under a profit-sharing agreement. Buyers of Experion's clones are newly licensed cultivators looking for quality genetics to launch their cultivation process for both the medical and adult-use markets. Experion has supplied over 2,500 clones over the last three months to licensed cultivators throughout BC and Alberta. Under the Cannabis Act, a cultivation license can sell product to other licensed facilities allowing Experion to foster new business to business ('B2B') relationships and the ability to create quick strategic partnerships as the market becomes established.


Mr. Jay Garnett, Chief Executive Officer, commented, 'Experion strongly believes in the Micro-Cultivation and Craft Growing industry, and we are excited to be supporting the participants in this sector. Partnering with new cultivators enables Experion to accomplish a myriad of goals while adding shareholder value. By offering new cultivators proven genetics, sound guidance and advice, and distribution options for their product, Experion benefits from another revenue source, increased capacity and potential expansion of our product offering in the marketplace under the Citizen Stash brand. Micro-Cultivators' unique abilities and commitment to quality enhances the Cannabis industry, and we are proud to be working with one of the first licensed in Canada.'


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivatior and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
Email: judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium Reports Q1 Results, Provides Corporate Update in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / April 29, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSX-V: VIR) (OTC PINK: VIRFF) is pleased to provide shareholders with the Q1 financials and a corporate update.


Financials


Viridium has now filed its Q1 2019 consolidated interim financial statements, and management discussion and analysis for the period ending February 28, 2019 on SEDAR.


Business Update


Viridium and its wholly-owned subsidiary, Experion Biotechnologies ("Experion"), a licensed cultivator and processing company under the Cannabis Act, are gaining traction on many of management's strategic goals since the last update. The Company continues to support the wholesale and starting materials markets throughout Canada with several new wholesale customers onboarding over the past month. Management recently visited several cultivation facilities throughout Western Canada fostering supply agreements and buy back programs.


Experion's sought-after retail flower, Citizen Stash, intended for the Adult-Use market is now available in BC and Saskatchewan. Initial orders for both provinces sold out quickly with a 400% increase in re-orders, which were shipped in early April. Experion is actively working with several provincial government distributors in three other provinces with the aim of expanding retail sales.


On April 8, 2019, EFX Laboratories Inc. ("EFX"), another wholly-owned subsidiary of Viridium, commenced medical two-piece capsule sales through its strategic partnership with Broken Coast Cannabis Ltd. ("BCC"), a wholly-owned subsidiary of Aphria Inc. EFX commercially manufactures the medical two-piece capsules on behalf of Aphria through a revenue sharing agreement. This product offering contains various THC and CBD concentrations, and gives medical clients a dose-controlled, predictive, tasteless, odorless, and discreet option for consuming cannabis oil. Additionally, the whole-flower, full spectrum capsule is one of few available in the Canadian cannabis market resulting in a unique selling position. The product is available to medical clientele via BCC's online sales portal.


On April 9, 2019, Health Canada conducted its annual inspection of Experion's facility under the Cannabis Act. The inspection consisted of three inspectors over a two-day period resulting in no issues or observations, and a continued high compliance rating for all Experion's licenses and sub-licenses. Experion is setting the standard for quality assurance and compliance in the industry.


Canopy expansion and GMP certification renovations are underway at Experion's Mission facility; ultimately, increasing cultivation and processing areas by 60% and integrating extraction capabilities under GMP processing when complete.


Corporate Update


The company engaged Judy-Ann Pottinger of Vancouver, British Columbia, to provide comprehensive investor relations, corporate communications and investor outreach services. Ms. Pottinger will develop and manage Viridium's corporate communications program to increase awareness of the Company to the investment community including existing shareholders, potential investors, analysts, brokers, Wealth Fund managers and other key influencers interested in the ever-changing and burgeoning Cannabis industry.


In addition, on April 23, 2019, the Company's Compensation Committee approved the return to treasury of RSU's with a value of $250,000 in exchange for a cash bonus $250,000 in relation to an officer's employment agreement. The cash payment will be paid on May 9, 2019.


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechologies Inc., a Health Canada licensed cultivation and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


Disclosure
This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium to Host Investor Conference Call in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / April 18, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC: VIRFF) is pleased to announce that the Company will host a conference call on Thursday May 2, 2019 at 1:15PM PST / 4:15PM EST to provide a Corporate update to its shareholders and investment community.


Mr. Jay Garnett, Chief Executive Officer, commented, "We are very excited about the momentum we have achieved to date. We look forward to discussing the Company's progress on the conference call and explaining our strategy and commitment to building long-term value for our shareholders."


The call will be hosted by Jay Garnett, Chief Executive Officer, and will be available for replay on the Viridium's website. Interested parties who wish to join the conference call, may register by emailing ir@experionwellness.com to get the dial in and access code. The call will not allow for Q&A, but if you have questions, you can email them ahead of the call and we will endeavor to respond to those questions in the presentation.


There will also be a playback of the conference call posted on the company website viridiumpacific.com under the MEDIA Tab. https://www.viridiumpacific.com/media/


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechologies Inc., a Health Canada licensed cultivation and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact:


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.

!

Experion Holdings Ltd.

publicPublic Group

Experion Holdings Ltd. is the parent company of Experion Biotechologies Inc., a Health Canada licensed cultivation and processor of Cannabis, based in Mission, BC; and EFX Labs, a medical products production and clinical research company based in Calgary, AB.

people16 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
  • Thumb 20190424 083700 film4 1
Join Group


Experion Holdings Ltd.

publicPublicGroup

Experion Holdings Ltd. is the parent company of Experion Biotechologies Inc., a Health Canada licensed cultivation an......

people16 Members       (0)

Judy-Ann Pottinger posted an update WHAT HAPPENS WHEN THE ‘’HIGH’’ WEARS OFF? in EXPERION HOLDINGS LTD.

Dear Investors and Members


The cannabis sector has seen a lot of shake-ups in the last quarter and that in and of itself is an understatement. 


The sector seems to swing back and forth, week to week, even day to day. Sometimes based on big news, but sometimes not. Sometimes the news is on a single company.  In the last weeks we have seen Canopy bid farewell to its Founder, Aphria saw its two co-founders and former chief executive exit stage left and CannTrust’s former co-founder and CEO step down, but let’s not get lost in the weeds


Why all this change – this shuffle?  Greg Taylor, chief investment officer of Purpose Investments, which runs the Purpose Marijuana Opportunities Fund said this “Look, the industry needs to mature. These people founded companies on the concept of cannabis legalization, and now it has happened, so there needs to be a focus on operations. Your products have to be up and running and good,”


“All these companies are now going to have to look at their management and see if they are actually up for this task of delivering the goods.”


https://business.financialpost.com/cannabis/cannabis-business/lintons-firing-signals-it-is-time-for-cannabis-industry-to-start-delivering


Over the past 7 to 10 days I have spoken to a plethora of Experion shareholders and investors looking at Experion who have asked about Experion and specifically wanting to know more about Jay Garnett our CEO.  One of those conversations really resonated with me and frankly I thought ‘’Eureka’’ – THIS is it!!! Let me share it with you  ‘’Hey Judy-Ann what’s the one business acumen that stands out most when it comes to Jay Garnett, from what I can gather thus far, he is a master of splitting a dollar into four and keeping burn rates down….”


Bigger does not translate into better… Jay Garnett stepped into the CEO of Experion (formerly Viridium Pacific) in October 2018 with a mandate to steer the company through its next phase of growth.  A huge task but one Garnett is more than capable of doing.  His Curriculum Vitae boasts a long history of ‘’building companies’’, ‘’re-building companies’’ and he knows how to build a Team.


“Throughout my entrepreneurial career, I have focused on being ahead of consumer trends, behavioral shifts and finding ways to bridge product offerings with consumer desires.  Now at Experion I have a unique opportunity to define and educate the market through one of the largest shifts in consumer goods in history” Jay Garnett – October 15, 2018


https://www.experionwellness.com/viridium-pacific-group-names-new-ceo-2/


“We’re in the cannabis space, and I think for a lot of people that that’s very confusing. I think there are so many licenses out there and people don’t really understand how the Health Canada’s licensing system works so, if I was going to break it down, I would say that we are a licensed cultivator and seller of cannabis within the industry, and our goal is to ensure that our quality cannabis is vertically integrated from there into our own products, primarily focused in the medical space.”  Jay Garnett


Not overly complicated. Grow it well, then put it out through a series of pipelines to whomever wants to buy it for a premium.  That doesn’t require tens of millions of dollars raised every few months for ongoing hype sales letters on Instagram. Just do the work. Right? Jay Garnett – June 3, 2019 Equity Guru interview with Chris Parry


https://equity.guru/2019/06/03/experion-biotechnologies-vir-v-starts-telling-story-get-savings/


Follow us in Experion’s Global Investor Forum for continued updates and insights  http://connects.company/ExperionEXP


 

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Holdings Ltd. Trading on Frankfurt Stock Exchange Under New Company Name in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / July 3, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31), formerly Viridium Pacific Group Ltd., announced today that its shares are now trading on the Frankfurt Stock Exchange under the Company's new name Experion Holdings Ltd. The symbol and WKN have not changed and remains ''MB31" and ''WKN:A2PLZG".


The Company's shares continue to be listed on the TSXV under the ticker ''EXP" and on the OTCQB market in the US under the ticker "EXPFF"


Mr. Jay Garnett, Chief Executive Officer commented, "Experion is pursuing international growth strategies, such as the vast export market in countries with early opportunities. Having our new name reflected on the Frankfurt Stock Exchange will allow us to grow our shareholder base throughout Europe and attract global recognition as we work diligently to unlock value for our current shareholders and new shareholders to come"


The Frankfurt Stock Exchange is one of the world's largest trading centres for securities. With a share in turnover of around 90 per cent, it is the largest of Germany's seven stock exchanges and it is an international trading centre, which is reflected in the structure of its participants. Of the approximately 200 market participants, roughly 50% are from countries other than Germany.


On June 25th Experion announced an LOI with a Polish Import and Distribution Company. The LOI will see Experion exporting medical flower products to Poland for scientific purposes enabling the Polish Company to test and develop Experion's flower products. Ultimately Experion's goal is to export increased quantities of its flower products into Poland for medical use.


Mr. Jay Garnett further commented "As investor interest and momentum in the cannabis industry continues to accelerate, Experion will be well-positioned to participate in the European and global cannabis markets as they continue to expand, and we receive our EU GMP certification that will allow Experion products to be exported across Europe."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/550713/Experion-Holdings-Ltd-Trading-on-Frankfurt-Stock-Exchange-Under-New-Company-Name

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Announces Letter of Intent with Polish Import and Distribution Company in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 25, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31), formerly Viridium Pacific Group Ltd., is pleased to announce that it has signed a non-binding Letter of Intent (''LOI'') with a Polish Import and distribution Company (''Polish Company'') to export medical flower products to Poland for scientific purposes.


The executed LOI consist of two parts, part one, will see Experion exporting medical flower products to Poland for scientific purposes enabling the Polish Company to test and develop Experion's flower products. Upon the successful testing and development of the flower products and once a viable export and import channel has been established between Canada and Poland, part two of the LOI will commence which will see Experion exporting increased quantities of its flower products into Poland for medical use. Experion will also have completed its EU GMP certification which will allow for part two of the LOI.


Mr. Jay Garnett, Chief Executive Officer commented, "The LOI represents a major milestone for Experion. As medical marijuana becomes more legalized around the world, Experion continues to focus on the vast export market in countries with early opportunities. By exporting products for scientific research, we are able to move past barriers to entry and be one of the first Canadian producers to enter Poland"


Pursuant to the LOI, Experion and the Polish Import Company will work towards a definitive agreement as Experion seeks to increase export opportunities in Europe and continue to build Experion's international distribution chain.


Mr. Jay Garnett further commented "I am truly proud of the work that the team has done and the great strides we have made to date. This is yet another result of solid teamwork that can only be achieved by having a shared vision and goal as we work diligently to unlock value for our most important asset and audience - our shareholders.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/549774/Experion-Announces-Letter-of-Intent-with-Polish-Import-and-Distribution-Company

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion's Brand, Kanabé Goods Co., Well Positioned to Take Advantage of New Health Canada Regulations in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 21, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF), formerly Viridium Pacific Group Ltd., is pleased to provide an update on the Company's brands positioned to take advantage of Health Canada's final regulations for Value-Add Products (VAP's) such as cannabis topicals, edibles and extracts as well as Health Canada's proposal to create a new category ''Cannabis Health Products'' for therapeutic treatment of minor ailments like sleeplessness or sore muscles or for use in pets, paving the way for large new untapped market.


Mr. Jay Garnett, Chief Executive Officer commented "Experion is in continued development of our wellness-centric brand Kanabé Goods Co. www.kanabe.ca for the launch of value-add products (VAP's). There are currently 50 plus existing formulations which we have the ability to produce in our facility and we are also working with key strategic partners for large scale commercial roll-out. These health and wellness products such as non-intoxicating topicals and micro-dosed oils are an entry point for new consumers, broadening the market potential. The Experion management team has decades of experience in consumer-packaged goods and is well positioned to be a first mover in this category which in turn will enable Experion to stand firm in our commitment of unlocking value for our shareholders"


The VAP's regulations come into force October 17, 2019 with product availability earliest December 16th, 2019. Furthermore, Health Canada's proposal for Cannabis Health Products opens the door for a bigger opportunity. The proposal looks to treat health and wellness products with cannabis, similar to Natural Health Products which allows the product to make health claims based on evidence but without the oversight of a practitioner.


Mr. Garnett further commented "A Kanabé topical balm that is non-intoxicating, for example, could potentially be sold via pharmacies or online without the restrictions to have a medical cannabis prescription or buy through a licensed cannabis retailer. The accessibility to purchase is much easier on the consumer, as well as the use of the product much clearer." This proposal further aligns to our educational and public outreach efforts from our Cannabis Wellness Expert and Co-Founder of Kanabé, Krystal Laferriere, who had created the product line to soothe side-effects and other ailments suffered as a result of her Crohn's Disease."


Health Canada is asking the public to submit feedback on this new category via consultation paper until September 3rd.


https://www.canada.ca/en/health-canada/programs/consultation-potential-market-cannabis.html


Health Canada Final Regulations for Value-Add Products


https://www.canada.ca/en/health-canada/news/2019/06/health-canada-finalizes-regulations-for-the-production-and-sale-of-edible-cannabis-cannabis-extracts-and-cannabis-topicals.html


About Kanabe Goods Co


Kanabé Goods Co. www.kanabe.ca creates therapeutic health and wellness products containing cannabis and has over 50 formulations in its portfolio including topical salves, lotions, oils as well as edible oils and capsules. Kanabé products were developed to target and soothe various aliments by combining cannabinoids, terpenes and aromatherapy with a focus on discretion and ease of use by developing products that are already found in consumers everyday life. Kanabé is an adult-use, over-the-counter health & wellness brand ingraining into daily actions and rituals for comfort and solutions to acute problems ranging from sore muscles, to sleep and skin issues.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Experion Holdings Ltd
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd


View source version on accesswire.com:
https://www.accesswire.com/549436/Experions-Brand-Kanab-Goods-Co-Well-Positioned-to-Take-Advantage-of-New-Health-Canada-Regulations

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Holdings Ltd Announces Its U.S. Listing on OTCQB Under the Symbol EXPFF in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 19, 2019 / Experion Holdings Ltd. ("Experion" or the  "Company") (TSX-V: EXP) (OTCQB: EXPFF), formerly Viridium Pacific Group Ltd., today announced it has qualified to trade on the OTCQB Venture Market. Experion also has the intention to seek The Depositary Trust Company ("DTC") eligibility.


The common shares of Experion will begin trading on the OTCQB, effective immediately, under the ticker symbol "EXPFF." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.


Mr. Jay Garnett, Chief Executive Officer, commented "We are proud to qualify for a listing on the OTCQB marketplace.  This is an important step and milestone for the Company as it aims to increase its presence among American retail and institutional investors. This move will provide investors with additional liquidity and increased trading capacity and reaffirms to the markets that we are indeed committed to unlocking value for our shareholders".


Experion will continue to trade on the TSX Venture Exchange under its existing symbol "EXP".


About OTCQB Venture


The OTCQB Venture is the premier marketplace for entrepreneurial and development stage U.S. and international companies that are committed to providing a high-quality trading and information experience for their US investors. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB Venture quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB. 


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd 


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com 


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/549207/Experion-Holdings-Ltd-Announces-Its-US-Listing-on-OTCQB-Under-the-Symbol-EXPFF

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Announces Resignation of Board Member in EXPERION HOLDINGS LTD.

VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / June 17, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP), formerly Viridium Pacific Group Ltd., wishes to announce that Michael Kohut has resigned from the board of directors of Experion effectively immediately.


Mr. Jay Garnett, Chief Executive Officer, commented, "We would like to thank Mike for his efforts and contributions. We are in the process of evaluating candidates that will strengthen our board and support management in unlocking value for all shareholders."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548952/Experion-Announces-Resignation-of-Board-Member

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Adds Veteran Financial and Business Magnate to Board of Directors with the Appointment of William (Bill) Kenneth Dickie in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 11, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSX-V: EXP), formerly Viridium Pacific Group Ltd., is pleased to announce the appointment of a new member to its Board of Directors. Mr. William (Bill) Kenneth Dickie will join Mr. Jay Garnett, Chief Executive Officer of Experion Holdings Ltd, on the Board of Directors effective June 11, 2019.


Mr. Dickie brings substantial financial oversight and business advisory experience to Experion's Board. Mr. Dickie is currently, the Co‐Chief Investment Officer and a Portfolio Manager at Matco Financial, a Calgary, Alberta based independent discretionary investment counsellor and asset management firm. Mr. Dickie has over thirty-five (35) years of experience in the financial and investment industry, and is responsible for the investment operations and strategic development of Matco Financial Inc. He is a member of the Investment Committee, Asset Mix Committee and Chair of the Equity Working Group. As the Co-Chief Investment Officer of Matco Financial Inc., he has oversight of the Matco Investment Platform.


Mr. Dickie has been helping private clients achieve their goals since 1979, starting his career with McLeod Young Weir Ltd. Prior to co-founding Matco Financial Inc. in 2006, Mr. Dickie was President and Director of Fiduciary Trust Company of Canada, formerly part of Bissett Investment Management. where he established a new business strategy and model. Mr. Dickie graduated from the University of Alberta having earned a Bachelor of Commerce and holds the Chartered Financial Analyst designation.


"Bill brings a wealth of financial and governance expertise" said Jay Garnett, CEO of Experion Holding Ltd. "his appointment furthers our commitment to a strong and relevant board. Bill's addition to the Board is significant as he brings deep knowledge of the cannabis industry through his role as Co-Chief Investment Officer and one of the Lead Portfolio Managers of the Matco's Cannabis Fund; as well as extensive financial and deal-making skills. His firsthand approach to mentoring and building new companies in fast growing industries will be invaluable to Experion. We look forward to Bill's guidance as we continue to execute on our strategic objectives for 2019 to unlock value and grow Experion's market valuation."


Mr. Dickie was an early investor in EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, Alberta, which Experion acquired in February 2019.


Mr. Dickie commented, "I am pleased to be joining the Board of Experion at this important inflection point in the Company's history within an exciting and dynamic market environment. As Experion embarks on a period of tremendous growth and differentiation, I look forward to working with Jay and the management team".


Resignation of Sean McNeil


Mr. Sean MacNeil has recently resigned from his position as a Director on Experion's Board of Directors to focus on other matters. Mr. Jay Garnett added, "We wish to sincerely thank Sean for his important contributions as a key contributor in the Company's evolution and growth over the last several years. We wish him well in his future endeavors."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd


View source version on accesswire.com:
https://www.accesswire.com/548360/Experion-Adds-Veteran-Financial-and-Business-Magnate-to-Board-of-Directors-with-the-Appointment-of-William-Bill-Kenneth-Dickie

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium Pacific Group Ltd. Announces Name Change to Experion Holdings Ltd. in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 10, 2019 / Viridium Pacific Group Ltd. (the ''Company") (TSX-V: VIR ) is pleased to announce that the Company has changed its name from "Viridium Pacific Group Ltd." to "Experion Holdings Ltd." (TSX-V: EXP).The Company's shareholders approved the name change at a special meeting of shareholders held on May 31, 2019. Effective on market opening on June 10, 2019, the common shares of the Company will commence trading on the TSX Venture Exchange under the Company's new name, Experion Holdings Ltd., and under the trading symbol ''EXP". With the new change in name, there is no consolidation of capital and the CUSIP Number will be 30219B109.


Mr. Jay Garnett, Chief Executive Officer, commented, "We are excited to have both our Licence and corporate entity under Experion. Having a focused brand strategy, under one corporate brand, will bring alignment to the market and our shareholders. In addition, it will allow us to better communicate our value proposition as we work to unlock value and communicate our accomplishments to the market and stakeholders."


No action is required to be taken by current shareholders in connection with the change in name and no change has been made to Experion Holdings Ltd. share capital.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


A new Company website will be rolled out in the following weeks, for now please visit www.viridiumpacific.com or contact our Investor Relations Consultant (details below) for further information.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548214/Viridium-Pacific-Group-Ltd-Announces-Name-Change-to-Experion-Holdings-Ltd

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Biotechnologies Inc's Krystal Laferriere Sits on Panel at Lift & Co Expo Consumer Weekend in EXPERION HOLDINGS LTD.

VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / June 8, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) the parent company of Experion Biotechnologies Inc. ("Experion"), a Health Canada licensed cultivator and processor of Cannabis is pleased to announce that the Company will take part in a panel discussion at the Lift & Co. Expo Consumer Weekend on June 9th in Toronto.


Krystal Laferriere, Marketing Manager Experion Wellness, will sit on a panel with industry heavyweights such as Dr. Ira Price, Assistant Clinical Professor Emergency Medicine at McMaster University, and NextLeaf Solutions CEO, Paul Pedersen. The panel discussion will take place at the Expo Consumer Weekend on Sunday June 9th at 2:20pm to 3:00pm EST on Cannabis, Clarity & Wellness - New and Overdue Treatments and Therapies.


CEO Jay Garnett commented "We are excited to have Krystal be a key contributor and presenter at the upcoming Lift & Co Expo. Krystal is Experion's ambassador, a trusted and resonant voice in the medical Cannabis space. Krystal has fostered a large following on social media primarily because of her personal struggles with Crohn's disease and her ultimate discovery of cannabis as a therapy. Having Krystal as Experion's Cannabis Wellness Expert spearheading cannabis education, marketing and brand ambassadorship, enables Experion to have an authentic voice as we position Experion to be a dominant producer of a wide spectrum of cannabis products in the near future."


We invite all attendess of the Lift & Co Expo to join us on Sunday, June 9th at 2:20 pm to 3:00 pm.


CEO Jay Garnett further commented "We are excited about the many ways our products can enhance wellness, helping people sleep better and alleviating a range of chronic conditions. We are proud of our progress in the pain management field, particularly with our two-piece pill. It is the only cannabis product in Canada to have reached stage three clinical trials for post-operative pain relief."


Lift & Co. (TSXV: LIFT) is a cannabis-focused technology and media company that monetizes a platform of advertising solutions, events, and data insights to enable cannabis businesses to better understand, target and ultimately monetize cannabis consumers. Lift & Co. operates a leading product-comparison resource of federally regulated cannabis products; provides customized marketing solutions and data-backed insights into consumer and product trends; and connects businesses and consumers through its digital platform, and at its leading events, the Retail Tradeshows, the Lift & Co. Expos and the Canadian Cannabis Awards. The Lift & Co. Cannabis Retail Training Certification, developed in an exclusive partnership with MADD Canada, is available to both government and private clients. Learn more at lift.co.


Viridium Pacific Group Ltd. and its wholly owned subsidiary, Experion Biotechnologies Inc., together with one of its directors and several other named defendants were named in a civil claim filed by an ex-CEO of Viridium, Stephen Serenas. Mr. Serenas is seeking damages among other remedies, for breach of contract and wrongful dismissal for his employment as CEO of Viridium in the form of 10,270,437 shares of Viridium, or, alternatively, $5,546,035 as cash in lieu of the shares; in addition to 149,625 restricted stock units fully vested in Viridium. Management considers this claim to be without merit and both Viridium and Experion intend to vigorously defend the action.


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact:


Viridium Pacific Group Ltd.


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8.


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548151/Experion-Biotechnologies-Incs-Krystal-Laferriere-Sits-on-Panel-at-Lift-Co-Expo-Consumer-Weekend

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium Pacific Group Announces Results Of Annual General Meeting in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 6, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) is pleased to announce the results of its annual general and special meeting of shareholders held on May 31, 2019 (the "Meeting").


The Company put forward the following resolutions to be voted on by shareholders at the Meeting, all of which were approved:


(i) Appointment of MNP LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.


(ii) Fixing the number of directors of the Company at seven (7);


(iii) The election of directors - 01. Michael Black 02. Joel Dumaresq 03. Deni Echino 04. Jay Garnett 05. Michael Kohut 06. Sean MacNeil 07. Harry McWatters


(iv) Approve a special resolution to change the name of the Corporation to Experion Holdings Ltd.


(v) Approval of the Corporation's stock option plan


Each of the directors elected at the meeting being, Michael Black, Joel Dumaresq, Deni Echino, Jay Garnett, Michael Kohut, Sean MacNeil and Harry McWatters will hold office until the next annual meeting of the Company or until their earlier resignation or removal. Mr. Harry McWatters accepted the role of Chairman for the ensuing year, Mr. Joel Dumaresq was appointed the Audit Chair and Mr. Michael Black was appointed the Compensation and Nominations Chair.


In addition, the Company granted 156,250 Restricted Stock Units ("RSUs") to its directors and a former director, of which 25,000 RSUs will vest on May 31, 2020 and the remaining 131,250 RSUs will vest 12 months after the directors resign.


CEO Jay Garnett commented. "We are pleased to have our board elected with high acceptance of our voting shareholders. Having a strong Board is fundamental to Experion as we move forward with our strategy to unlock value and grow Experion's valuation in the marketplace. Our focused mandate to unlock value in our licenses, in our team and in our strategy gives Experion a sound footing in building a progressive cannabis company regionally, nationally and internationally."


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/547926/Viridium-Pacific-Group-Announces-Results-Of-Annual-General-Meeting

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Biotechnologies Inc's Krystal Laferriere Sits on Panel at Lift & Co Expo Consumer Weekend in EXPERION HOLDINGS LTD.

VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / June 8, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) the parent company of Experion Biotechnologies Inc. ("Experion"), a Health Canada licensed cultivator and processor of Cannabis is pleased to announce that the Company will take part in a panel discussion at the Lift & Co. Expo Consumer Weekend on June 9th in Toronto.


Krystal Laferriere, Marketing Manager Experion Wellness, will sit on a panel with industry heavyweights such as Dr. Ira Price, Assistant Clinical Professor Emergency Medicine at McMaster University, and NextLeaf Solutions CEO, Paul Pedersen. The panel discussion will take place at the Expo Consumer Weekend on Sunday June 9th at 2:20pm to 3:00pm EST on Cannabis, Clarity & Wellness - New and Overdue Treatments and Therapies.


CEO Jay Garnett commented "We are excited to have Krystal be a key contributor and presenter at the upcoming Lift & Co Expo. Krystal is Experion's ambassador, a trusted and resonant voice in the medical Cannabis space. Krystal has fostered a large following on social media primarily because of her personal struggles with Crohn's disease and her ultimate discovery of cannabis as a therapy. Having Krystal as Experion's Cannabis Wellness Expert spearheading cannabis education, marketing and brand ambassadorship, enables Experion to have an authentic voice as we position Experion to be a dominant producer of a wide spectrum of cannabis products in the near future."


We invite all attendess of the Lift & Co Expo to join us on Sunday, June 9th at 2:20 pm to 3:00 pm.


CEO Jay Garnett further commented "We are excited about the many ways our products can enhance wellness, helping people sleep better and alleviating a range of chronic conditions. We are proud of our progress in the pain management field, particularly with our two-piece pill. It is the only cannabis product in Canada to have reached stage three clinical trials for post-operative pain relief."


Lift & Co. (TSXV: LIFT) is a cannabis-focused technology and media company that monetizes a platform of advertising solutions, events, and data insights to enable cannabis businesses to better understand, target and ultimately monetize cannabis consumers. Lift & Co. operates a leading product-comparison resource of federally regulated cannabis products; provides customized marketing solutions and data-backed insights into consumer and product trends; and connects businesses and consumers through its digital platform, and at its leading events, the Retail Tradeshows, the Lift & Co. Expos and the Canadian Cannabis Awards. The Lift & Co. Cannabis Retail Training Certification, developed in an exclusive partnership with MADD Canada, is available to both government and private clients. Learn more at lift.co.


Viridium Pacific Group Ltd. and its wholly owned subsidiary, Experion Biotechnologies Inc., together with one of its directors and several other named defendants were named in a civil claim filed by an ex-CEO of Viridium, Stephen Serenas. Mr. Serenas is seeking damages among other remedies, for breach of contract and wrongful dismissal for his employment as CEO of Viridium in the form of 10,270,437 shares of Viridium, or, alternatively, $5,546,035 as cash in lieu of the shares; in addition to 149,625 restricted stock units fully vested in Viridium. Management considers this claim to be without merit and both Viridium and Experion intend to vigorously defend the action.


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact:


Viridium Pacific Group Ltd.


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8.


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548151/Experion-Biotechnologies-Incs-Krystal-Laferriere-Sits-on-Panel-at-Lift-Co-Expo-Consumer-Weekend

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium Pacific Group Announces Results Of Annual General Meeting in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / June 6, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) is pleased to announce the results of its annual general and special meeting of shareholders held on May 31, 2019 (the "Meeting").


The Company put forward the following resolutions to be voted on by shareholders at the Meeting, all of which were approved:


(i) Appointment of MNP LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.


(ii) Fixing the number of directors of the Company at seven (7);


(iii) The election of directors - 01. Michael Black 02. Joel Dumaresq 03. Deni Echino 04. Jay Garnett 05. Michael Kohut 06. Sean MacNeil 07. Harry McWatters


(iv) Approve a special resolution to change the name of the Corporation to Experion Holdings Ltd.


(v) Approval of the Corporation's stock option plan


Each of the directors elected at the meeting being, Michael Black, Joel Dumaresq, Deni Echino, Jay Garnett, Michael Kohut, Sean MacNeil and Harry McWatters will hold office until the next annual meeting of the Company or until their earlier resignation or removal. Mr. Harry McWatters accepted the role of Chairman for the ensuing year, Mr. Joel Dumaresq was appointed the Audit Chair and Mr. Michael Black was appointed the Compensation and Nominations Chair.


In addition, the Company granted 156,250 Restricted Stock Units ("RSUs") to its directors and a former director, of which 25,000 RSUs will vest on May 31, 2020 and the remaining 131,250 RSUs will vest 12 months after the directors resign.


CEO Jay Garnett commented. "We are pleased to have our board elected with high acceptance of our voting shareholders. Having a strong Board is fundamental to Experion as we move forward with our strategy to unlock value and grow Experion's valuation in the marketplace. Our focused mandate to unlock value in our licenses, in our team and in our strategy gives Experion a sound footing in building a progressive cannabis company regionally, nationally and internationally."


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium Pacific Group Ltd. Becomes a Member of the 8020 Community and Announces Annual General Meeting to be Held May 31, 2019 in EXPERION HOLDINGS LTD.

VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / May 13, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) is pleased to announce that Viridium is now a member of the 8020 Connect Inc. ("8020 Connect") investor community.


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect.


Join here: http://connects.digital/Viridium8


The 8020 platform enables Viridium to keep the investment community abreast of current developments such as corporate updates and engage directly with investors through a social media portal. 8020 Connect was the first social media platform to connect existing and potential investors to the Executive Management teams of publicly traded companies. The interactive structure of the portal provides an opportunity for interested parties to communicate with Viridium and supports the development of the Company's investor audience.
Mr. Jay Garnett, Chief Executive Officer, commented: "Viridium is committed to increasing our engagement with our investment community. With the recent appointment of our Investor Relations Ambassador and now 8020 Connect's social media platform, we look forward to further direct communication with our stakeholders and investors."


Mr. D'Arcy Funfer, President of 8020 Connect, stated: "In addition to expanding our platform, 8020 Connect has been successfully expanding our investor network. This network will help Viridium, and other companies on our platform, launch their social media presence and increase their investor audience through active participation."


Annual General Meeting of Shareholders Announcement


Viridium Pacific Group Ltd. announces that its Annual General and Special Meeting of Shareholders (AGM) will be held at Suite 1600, 650 West Georgia Street, Vancouver, British Columbia on Friday May 31, 2019 at 11:00 a.m. (Pacific Time).


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.
Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


About 8020 Connect


8020 Connect Inc. is a social and interactive investment community portal which expands the way shareholders and interested investors access and gather information from public corporations. Built as a hybrid social media and shareholder and management engagement platform, corporations can direct the flow of information to prospective and existing investors through both static and dynamic content. This will allow public companies to build their investment brand and investor awareness while maintaining digital media and regulatory compliance in a growing online investment community.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.
Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.




View source version on accesswire.com:
https://www.accesswire.com/545114/Viridium-Pacific-Group-Ltd-Becomes-a-Member-of-the-8020-Community-and-Announces-Annual-General-Meeting-to-be-Held-May-31-2019

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Partners with Micro-Cultivators in the Emerging Craft Growing Industry in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / May 8, 2019 / Viridium Pacific Group Ltd. ('Viridium' or the 'Company') (TSX-V: VIR) (OTC PINK: VIRFF) is pleased to announce its wholly owned subsidiary, Experion Biotechnologies Inc. ('Experion'), a licensed cultivator and processing company under the Cannabis Act, recently supplied 600 clones to one of the first licensed Micro-Cultivators in Canada through a buy back option agreement.


Located in British Columbia ('BC'), the Micro-Cultivator received 600 clones with an option for Experion to purchase the flower back under a profit-sharing agreement. Buyers of Experion's clones are newly licensed cultivators looking for quality genetics to launch their cultivation process for both the medical and adult-use markets. Experion has supplied over 2,500 clones over the last three months to licensed cultivators throughout BC and Alberta. Under the Cannabis Act, a cultivation license can sell product to other licensed facilities allowing Experion to foster new business to business ('B2B') relationships and the ability to create quick strategic partnerships as the market becomes established.


Mr. Jay Garnett, Chief Executive Officer, commented, 'Experion strongly believes in the Micro-Cultivation and Craft Growing industry, and we are excited to be supporting the participants in this sector. Partnering with new cultivators enables Experion to accomplish a myriad of goals while adding shareholder value. By offering new cultivators proven genetics, sound guidance and advice, and distribution options for their product, Experion benefits from another revenue source, increased capacity and potential expansion of our product offering in the marketplace under the Citizen Stash brand. Micro-Cultivators' unique abilities and commitment to quality enhances the Cannabis industry, and we are proud to be working with one of the first licensed in Canada.'


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivatior and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
Email: judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium Reports Q1 Results, Provides Corporate Update in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / April 29, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSX-V: VIR) (OTC PINK: VIRFF) is pleased to provide shareholders with the Q1 financials and a corporate update.


Financials


Viridium has now filed its Q1 2019 consolidated interim financial statements, and management discussion and analysis for the period ending February 28, 2019 on SEDAR.


Business Update


Viridium and its wholly-owned subsidiary, Experion Biotechnologies ("Experion"), a licensed cultivator and processing company under the Cannabis Act, are gaining traction on many of management's strategic goals since the last update. The Company continues to support the wholesale and starting materials markets throughout Canada with several new wholesale customers onboarding over the past month. Management recently visited several cultivation facilities throughout Western Canada fostering supply agreements and buy back programs.


Experion's sought-after retail flower, Citizen Stash, intended for the Adult-Use market is now available in BC and Saskatchewan. Initial orders for both provinces sold out quickly with a 400% increase in re-orders, which were shipped in early April. Experion is actively working with several provincial government distributors in three other provinces with the aim of expanding retail sales.


On April 8, 2019, EFX Laboratories Inc. ("EFX"), another wholly-owned subsidiary of Viridium, commenced medical two-piece capsule sales through its strategic partnership with Broken Coast Cannabis Ltd. ("BCC"), a wholly-owned subsidiary of Aphria Inc. EFX commercially manufactures the medical two-piece capsules on behalf of Aphria through a revenue sharing agreement. This product offering contains various THC and CBD concentrations, and gives medical clients a dose-controlled, predictive, tasteless, odorless, and discreet option for consuming cannabis oil. Additionally, the whole-flower, full spectrum capsule is one of few available in the Canadian cannabis market resulting in a unique selling position. The product is available to medical clientele via BCC's online sales portal.


On April 9, 2019, Health Canada conducted its annual inspection of Experion's facility under the Cannabis Act. The inspection consisted of three inspectors over a two-day period resulting in no issues or observations, and a continued high compliance rating for all Experion's licenses and sub-licenses. Experion is setting the standard for quality assurance and compliance in the industry.


Canopy expansion and GMP certification renovations are underway at Experion's Mission facility; ultimately, increasing cultivation and processing areas by 60% and integrating extraction capabilities under GMP processing when complete.


Corporate Update


The company engaged Judy-Ann Pottinger of Vancouver, British Columbia, to provide comprehensive investor relations, corporate communications and investor outreach services. Ms. Pottinger will develop and manage Viridium's corporate communications program to increase awareness of the Company to the investment community including existing shareholders, potential investors, analysts, brokers, Wealth Fund managers and other key influencers interested in the ever-changing and burgeoning Cannabis industry.


In addition, on April 23, 2019, the Company's Compensation Committee approved the return to treasury of RSU's with a value of $250,000 in exchange for a cash bonus $250,000 in relation to an officer's employment agreement. The cash payment will be paid on May 9, 2019.


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechologies Inc., a Health Canada licensed cultivation and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


Disclosure
This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Viridium to Host Investor Conference Call in EXPERION HOLDINGS LTD.

VANCOUVER, BC / ACCESSWIRE / April 18, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC: VIRFF) is pleased to announce that the Company will host a conference call on Thursday May 2, 2019 at 1:15PM PST / 4:15PM EST to provide a Corporate update to its shareholders and investment community.


Mr. Jay Garnett, Chief Executive Officer, commented, "We are very excited about the momentum we have achieved to date. We look forward to discussing the Company's progress on the conference call and explaining our strategy and commitment to building long-term value for our shareholders."


The call will be hosted by Jay Garnett, Chief Executive Officer, and will be available for replay on the Viridium's website. Interested parties who wish to join the conference call, may register by emailing ir@experionwellness.com to get the dial in and access code. The call will not allow for Q&A, but if you have questions, you can email them ahead of the call and we will endeavor to respond to those questions in the presentation.


There will also be a playback of the conference call posted on the company website viridiumpacific.com under the MEDIA Tab. https://www.viridiumpacific.com/media/


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechologies Inc., a Health Canada licensed cultivation and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact:


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.

!